Moderna Inc (MRNA)
111.66
+3.68
(+3.41%)
USD |
NASDAQ |
Apr 29, 16:00
111.65
0.00 (0.00%)
After-Hours: 19:13
Moderna Cash from Investing (Quarterly): -538.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -538.00M |
| September 30, 2023 | 789.00M |
| June 30, 2023 | 1.944B |
| March 31, 2023 | 2.011B |
| December 31, 2022 | -1.048B |
| September 30, 2022 | 945.00M |
| June 30, 2022 | -1.152B |
| March 31, 2022 | -3.921B |
| December 31, 2021 | -1.138B |
| September 30, 2021 | -3.327B |
| June 30, 2021 | -3.878B |
| March 31, 2021 | -180.00M |
| Date | Value |
|---|---|
| December 31, 2020 | -190.00M |
| September 30, 2020 | -1.179B |
| June 30, 2020 | 13.00M |
| March 31, 2020 | -316.00M |
| December 31, 2019 | 130.29M |
| September 30, 2019 | 113.37M |
| June 30, 2019 | -246.90M |
| March 31, 2019 | -11.76M |
| December 31, 2018 | 6.173M |
| September 30, 2018 | 116.08M |
| June 30, 2018 | -11.64M |
| March 31, 2018 | -483.70M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.921B
Minimum
Mar 2022
2.011B
Maximum
Mar 2023
-587.80M
Average
-246.90M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -2.924B |
| Merck & Co Inc | 53.00M |
| Pfizer Inc | -11.00B |
| Johnson & Johnson | -1.202B |
| Novavax Inc | -9.078M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 622.00M |
| Cash from Financing (Quarterly) | -109.00M |
| Free Cash Flow | -3.825B |
| Free Cash Flow Per Share (Quarterly) | 1.052 |
| Free Cash Flow to Equity (Quarterly) | 402.00M |
| Free Cash Flow to Firm (Quarterly) | 402.00M |
| Free Cash Flow Yield | -8.85% |